Search results
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 1 day agoThe company's next dividend payment will be US$0.42 per share, and in the last 12 months, the...
Morgan Stanley Raises Pfizer (NYSE:PFE) Price Target to $29.00
ETF DAILY NEWS· 8 hours agoPfizer (NYSE:PFE – Free Report) had its price target boosted by Morgan Stanley from $28.00 to $29.00 in a research report report published on Thursday, ...
Pfizer (NYSE:PFE) Earns Outperform Rating from BMO Capital Markets
ETF DAILY NEWS· 8 hours agoBMO Capital Markets reaffirmed their outperform rating on shares of Pfizer (NYSE:PFE – Free Report) in a report issued on Thursday, Benzinga reports. BMO Capital Markets currently ...
3 No-Brainer Stocks to Buy in May
Motley Fool via Yahoo Finance· 5 hours agoIt may not be an easy path forward for the healthcare company, but given the significantly reduced price tag the stock trades at, it's easy to justify...
Pfizer earnings beat by $0.29, revenue topped estimates By Investing.com
Investing.com· 4 days agoPfizer earnings beat by $0.29, revenue topped estimates
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 5 days agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 3 days agoPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 4 days agoPfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings release, which saw the storied...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 1 day agoBoth stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance via AOL· 4 days agoPfizer also faces the expiration of patents on some of its biggest drugs, including breast cancer...